BioCentury
ARTICLE | Company News

Amgen updates Aranesp progress

June 29, 2001 7:00 AM UTC

AMGN said the company will not receive FDA approval for Aranesp modified erythropoietin in the first half of this year as it had expected, but said that discussions with the FDA are progressing. AMGN ...